The GVT effect is most commonly associated with hematologic cancers such as [leukemia]( ), [lymphoma]( ), and [multiple myeloma]( ). It has also shown promise in treating some solid tumors, though this is an area of ongoing research. The effectiveness of GVT in different cancer types depends on various factors, including the immunogenicity of the tumor and the compatibility of the donor and recipient.
